Faculty profile
Jean Arbour
Back to facultyResearch
Read how they describe their research on their Université de Montréal profile.
Latest funding
- $403,623
Azacyclopeptide Modulators of Immuno-metabolism to Treat Age-Related Macular Degeneration
CIHR · 2018 · Co-investigator
No publications available.
Azacyclopeptide Modulators of Immuno-metabolism to Treat Age-Related Macular Degeneration
Principal investigators: Lubell, William D; Chipperton, Paul; Chemtob, Sylvain
Keywords: Age-Related Macular Degeneration; Azacyclopeptide; Cluster Of Differentiation-36 Receptor (Cd36); Inflammation; Macrocyclization; Macrophage; Medicinal Chemistry; Optometry; Organic Synthesis; Peptide Science
From public funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998 with their latest competition results, the Canada Foundation for Innovation, Genome Canada, the Canadian Space Agency, Canada Research Chairs, the Fonds de recherche du Québec, Ontario research funding, Michael Smith Health Research BC, the Canadian Cancer Society, Heart & Stroke and Brain Canada.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.